Sigilon Therapeutics Inc (SGTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2017 | |
| Sales | 12,944 | 9,599 | 13,374 | 14,155 | 0 |
| Gross Profit | 12,944 | 9,599 | 13,374 | 14,155 | N/A |
| Operating Expenses | 56,610 | 85,235 | 66,016 | 58,278 | 0 |
| Operating Income | -43,666 | -75,636 | -52,642 | -44,123 | N/A |
| Interest Expense | 2,290 | 1,988 | 1,202 | 650 | 0 |
| Other Income | 2,395 | 313 | -764 | 848 | 0 |
| Pre-tax Income | -43,561 | -77,311 | -54,608 | -43,925 | 0 |
| Net Income Continuous | -43,561 | -77,311 | -54,608 | -43,925 | N/A |
| Net Income | $-43,561 | $-77,311 | $-54,608 | $-43,925 | $N/A |
| EPS Basic Total Ops | -17.43 | -31.60 | -98.18 | -139.66 | N/A |
| EPS Basic Continuous Ops | -17.48 | -31.56 | -98.22 | -139.62 | N/A |
| EPS Diluted Total Ops | -17.43 | -31.60 | -98.18 | -139.66 | N/A |
| EPS Diluted Continuous Ops | -17.48 | -31.56 | -98.22 | -139.62 | N/A |
| EPS Diluted Before Non-Recurring Items | -17.43 | -31.60 | -3.51 | N/A | N/A |
| EBITDA(a) | $-42,394 | $-74,515 | $-51,788 | $-43,448 | $N/A |